DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. The company offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insurers, and health institutions. It sells its products to online mail-order pharmacies, and private individuals under the DocMorris, PromoFarma by DocMorris, and TeleClinic brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
Frequently asked questions
What sector does Zur Rose Group AG (ZRSEF) operate in?
Zur Rose Group AG belongs to the Consumer Staples sector and operates in the Pharmaceutical Retailers industry.
What is Zur Rose Group AG (ZRSEF) current stock price?
As of the latest data, Zur Rose Group AG stock price is $10.24, with a previous close of $10.24.
What is Zur Rose Group AG (ZRSEF) current market capitalization?
Zur Rose Group AG market cap is approximately 521.85 million.
What is Zur Rose Group AG (ZRSEF) Earnings Per Share (EPS)?
The trailing EPS is -$5.29.
What is Zur Rose Group AG (ZRSEF) EBITDA?
Zur Rose Group AG EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -19.91 million.
Does Zur Rose Group AG (ZRSEF) pay dividends?
No. Zur Rose Group AG does not pay a dividend.
What is Zur Rose Group AG (ZRSEF) beta (volatility) score?
Zur Rose Group AG has a beta of 1.780, suggesting it is more volatile than the market.